Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis C

NCT01596517 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

272

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a plus ribavirin for HCV genotype 1
DRUG: Peginterferon alfa-2a plus ribavirin for HCV genotype 2/3

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]